๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

8 recruiting trials

for Advanced Gastroenteropancreatic Neuroendocrine Tumor

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites๐Ÿ“ Iowa City๐Ÿ“ Boston๐Ÿ“ Royal Oak Novartis Pharmaceuticals ยท Tests: 225Ac-ETN029, 111In-ETN029 Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors NCT06840821Phase 1, Phase 21 site๐Ÿ“ Jinan Mainline Biosciences (Shanghai) Co., Ltd ยท Tests: MB0151 for injection An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors. NCT05884255Phase 32 sites๐Ÿ“ Shanghai๐Ÿ“ Tianjin Jiangsu HengRui Medicine Co., Ltd. ยท Tests: Lutetium (177Lu) Oxodotreotide Injection๏ผ›long-acting Octreotide, long-acting Octreotide Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs) NCT06937905Phase 340 sites๐Ÿ“ Angers๐Ÿ“ Avignon๐Ÿ“ Besanรงon Intergroupe Francophone de Cancerologie Thoracique ยท Tests: Standard of Care Chemotherapy, Tarlatamab Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors NCT05636618Phase 1, Phase 220 sites๐Ÿ“ Jacksonville๐Ÿ“ Miami๐Ÿ“ Orlando Perspective Therapeutics ยท Tests: [203Pb]VMT-ฮฑ-NET, [212Pb]VMT-ฮฑ-NET Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET NCT06784752Phase 367 sites๐Ÿ“ Scottsdale๐Ÿ“ Fayetteville๐Ÿ“ Denver Novartis Pharmaceuticals ยท Tests: [177Lu]Lu-DOTA-TATE, Octreotide LAR Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors NCT07080242Phase 124 sites๐Ÿ“ Huntsville๐Ÿ“ Glendale๐Ÿ“ Long Beach SystImmune Inc. ยท Tests: BL-M14D1 Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors NCT05048901Phase 1, Phase 211 sites๐Ÿ“ Changhua๐Ÿ“ Kaohsiung City๐Ÿ“ Kaohsiung City National Health Research Institutes, Taiwan ยท Tests: Cabozantinib, Lanreotide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy